{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:26:03Z","timestamp":1786983963197,"version":"build-2736575974"},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T00:00:00Z","timestamp":1702080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aaceclinicalcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Clinical Case Reports"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.aace.2023.12.004","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T20:04:24Z","timestamp":1702929864000},"page":"52-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Co-existence of Type 1 Diabetes Mellitus and Myasthenia Gravis: A\u00a0Case Report and Review of the Literature"],"prefix":"10.1016","volume":"10","author":[{"given":"Sabitha","family":"Sasidharan Pillai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5222-5787","authenticated-orcid":false,"given":"Kate","family":"Millington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.aace.2023.12.004_bib1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.dsx.2012.08.006","article-title":"Clinical profile of coexisting conditions in type 1 diabetes mellitus patients","volume":"6","author":"Kota","year":"2012","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"10.1016\/j.aace.2023.12.004_bib2","first-page":"73","article-title":"A\u00a0myasthenia gravis case diagnosed simultaneously with diabetic ketoacidosis","volume":"6","author":"Karacan K\u00fc\u00e7\u00fckali","year":"2019","journal-title":"J\u00a0Pediatr Res"},{"key":"10.1016\/j.aace.2023.12.004_bib3","first-page":"133","article-title":"Myasthenia gravis, primary adrenocortical insufficiency, and juvenile diabetes mellitus in a twelve-year-old boy","volume":"195","author":"Andler","year":"1983","journal-title":"KlinPadiat"},{"key":"10.1016\/j.aace.2023.12.004_bib4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/014107688908200621","article-title":"Diabetes mellitus and myastheniagravis in a patient with systemic onset juvenile chronic arthritis","volume":"82","author":"Jenkins","year":"1989","journal-title":"J\u00a0R Soc Med"},{"key":"10.1016\/j.aace.2023.12.004_bib5","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.12659\/AJCR.918996","article-title":"Humanleukocyte antigen (HLA) subtype- dependent development of myasthenia gravis, type-1 diabetes mellitus, and hashimoto disease: a case report of autoimmune polyendocrine syndrome type 3","volume":"20","author":"Gobaru","year":"2019","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.aace.2023.12.004_bib6","first-page":"A156.1","article-title":"G433(P) A child with juvenile myasthenia gravis in association with type 1 diabetes mellitus","volume":"105","author":"Woods","year":"2020","journal-title":"Arch Dis Child. BMJ"},{"issue":"4","key":"10.1016\/j.aace.2023.12.004_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J\u00a0Intern Med"},{"issue":"7","key":"10.1016\/j.aace.2023.12.004_bib8","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2337\/dc19-2003","article-title":"Cost and cost-effectiveness of large-scale screening for type 1 diabetes in Colorado","volume":"43","author":"McQueen","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.aace.2023.12.004_bib9","article-title":"T1D exchange quality improvement collaborative; understanding providers\u2019 readiness and attitudes toward autoantibody screening: a mixed-methods study","author":"Ospelt","year":"2023","journal-title":"Clin Diabetes"},{"issue":"1","key":"10.1016\/j.aace.2023.12.004_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S2213-8587(22)00351-5","article-title":"FDA approves teplizumab: a milestone in type 1 diabetes","volume":"11","author":"James","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.aace.2023.12.004_bib11","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ana.410130506","article-title":"Myasthenia gravis in children: long term follow-up","volume":"13","author":"Rodriguez","year":"1983","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.aace.2023.12.004_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102423","article-title":"Comparative United States autoimmune disease rates for 2010-2016 by sex, geographic region, and race","volume":"19","author":"Roberts","year":"2020","journal-title":"Autoimmun Rev"}],"container-title":["AACE Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060523001700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060523001700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T04:15:27Z","timestamp":1710735327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2376060523001700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2376060523001700"],"URL":"https:\/\/doi.org\/10.1016\/j.aace.2023.12.004","relation":{},"ISSN":["2376-0605"],"issn-type":[{"value":"2376-0605","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-existence of Type 1 Diabetes Mellitus and Myasthenia Gravis: A\u00a0Case Report and Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"AACE Clinical Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aace.2023.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of the AACE.","name":"copyright","label":"Copyright"}]}}